Surge In Clinical Trials Fuels The Antibody Contract Manufacturing Market Growth: The Driving Engine Behind Antibody Contract Manufacturing Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Antibody Contract Manufacturing Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the antibody contract manufacturing market has seen rapid expansion. Its size is expected to increase from $14.8 billion in 2024 to $16.84 billion in 2025, showcasing a compound annual growth rate (CAGR) of 13.8%. The past period's growth could be attributed to a rise in demand for monoclonal antibodies, a shift towards personalized medicine, cost optimization, strict regulatory requirements, and the globalization of biologics.

How Will the Antibody Contract Manufacturing Market Size Evolve and Grow by 2029?
The market of antibody contract manufacturing is predicted to undergo quick expansion in the forthcoming years, reaching a market value of $29.86 billion by 2029, progressing at a compound annual growth rate (CAGR) of 15.4%. This predicted growth during the forecast period could be due to a surge in R&D investment, proliferation of bispecific and multispecific antibodies, the emergence of antibody-drug conjugates (ADCs), advancements in healthcare facilities, and growing government programs. Key trends during this forecast period embrace the digital transformation and data analytics, cutting-edge upstream technologies, innovative downstream processing practices, sustainability movements, and the blending of contract development and manufacturing (CDMO).

View the full report here:
https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report

What Drivers Are Propelling the Growth of Antibody Contract Manufacturing Market Forward?
The antibody contract manufacturing market is expected to be driven by the increase in clinical trials. These trials involve human subjects and aim to assess the safety and efficacy of new medical treatments, methods, or diagnostic techniques. As the number of clinical trials incorporating antibody-based treatments or diagnostics grows, a high-quality, timely, and compliant supply of antibodies for these trials is essential. In May 2023, ClinicalTrials.gov, an entity of the National Institutes of Health (NIH), a government agency in the US dedicated to medical research, reported that the number of registered clinical trial studies increased from 399,499 in 2022 to 437,533 in 2023 across all 50 states and 221 countries. Furthermore, 241,498 studies, representing 53% of the total, were registered outside the US, compared to 140,492 studies (31%) registered solely within the US. Thus, the growing number of clinical trials is stimulating the expansion of the antibody contract manufacturing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12665&type=smp

Which Emerging Trends Are Transforming the Antibody Contract Manufacturing Market in 2025?
Major players in the antibody contract manufacturing market are directing their focus towards innovative development, specifically single-use technology to reduce the risk of cross-contamination and cut down on operations costs. Single-use technology (SUT) involves the use of disposable components in the biopharmaceutical manufacturing process. An example is the launch of the Mobius ADC Reactor by Merck & Co., a US pharmaceutical organization, in September 2024. This new reactor, designed specifically for producing antibody-drug conjugates, employs a single-use design to significantly increase production efficiency by 70%, relative to the traditional stainless steel or glass methodologies. The risks of cross contamination are decreased and operational costs are minimized, leading to quicker turnover periods. Also, the application of advanced film technology adds to the bag's strength and resistance, safeguarding the integrity of the highly potent active pharmaceutical ingredients. In essence, this innovative technology paves the way for biopharmaceutical firms to produce vital therapies in a safer and more efficient manner.

What Are the Key Segments in the Antibody Contract Manufacturing Market?
The antibody contract manufacturing market covered in this report is segmented -

1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products
2) By Source: Mammalian, Microbial
3) Scale Of Operation: Preclinical, Clinical, Commercial
4) By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users

Subsegments:
1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies, Diagnostic Monoclonal Antibodies
2) By Polyclonal Antibodies: Research Polyclonal Antibodies, Therapeutic Polyclonal Antibodies
3) By Other Products: Bispecific Antibodies, Antibody-Drug Conjugates (ADCs), Fusion Proteins

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12665&type=smp

Who Are the Key Players Shaping the Antibody Contract Manufacturing Market's Competitive Landscape?
Major companies operating in the antibody contract manufacturing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim Biopharmaceuticals GmbH, Fujifilm Holdings Corporation, Eurofins Scientific SE, Lonza Group AG, Labcorp Drug Development, Catalent Inc., Charles River Laboratories International Inc., Merck KGaA, Samsung Biologics Co. Ltd., Wuxi Biologics Cayman Inc, Siegfried Holding AG, Recipharm AB, Emergent BioSolutions Inc., Aenova Group, Cambrex Corporation, Aldevron LLC, Novasep Holding SAS, Synthon, KBI Biopharma Inc., Nitto Avecia Pharma Services Inc., Cytovance Biologics Inc., AGC Biologics S.p.A.

What Geographic Markets Are Powering Growth in the Antibody Contract Manufacturing Market?
North America was the largest region in the antibody contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12665

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.